Percutaneous Therapy for Renal Artery Fibromuscular Dysplasia

@article{Surowiec2003PercutaneousT,
  title={
Percutaneous Therapy for Renal Artery Fibromuscular Dysplasia
},
  author={Scott M. Surowiec and Nayan Sivamurthy and Jeffrey M. Rhodes and David E. Lee and David L. Waldman and Richard M. Green and Mark G Davies},
  journal={Annals of Vascular Surgery},
  year={2003},
  volume={17},
  pages={650-655}
}
Fibromuscular dysplasia (FMD) accounts for 10% of cases of renal artery stenosis. This study evaluates the anatomic and functional outcomes of endovascular therapy for symptomatic renal artery FMD at an academic medical center. A retrospective analysis of records from patients who underwent percutaneous transluminal renal artery angioplasty (PTRA) found 14 patients (all female) who underwent 19 interventions on 18 renal artery segments. Significant cardiovascular comorbidities were few in this… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 19 CITATIONS

Optimal management of renal artery fibromuscular dysplasia

  • Therapeutics and clinical risk management
  • 2014
VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED